The potentiality of out-of-cycle acute leukemic cells to synthesize DNA.
D000328:Adult; D000368:Aged; D001345:Autoradiography; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D004261:DNA Replication; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007945:Leukemia, Lymphoid / Q000097:blood* / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000097:blood; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000188:drug therapy; D007962:Leukocytes / Q000378:metabolism* / Q000528:radiation effects; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011830:Radiation Effects; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014466:Ultraviolet Rays; D014750:Vincristine / Q000627:therapeutic use
D014316:Tritium; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone; D013936:Thymidine; D008727:Methotrexate; D003630:Daunorubicin